continuous infusion

Type: Keyphrase
Name: continuous infusion
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

MS SQL Certification: Is It Worth The Time, Trouble and Test Taking?

It is no secret that the information technology job market is brutally competitive. Technology and innovations move fast and the sluggish pace of the recovery translates into more job applicants than job openings. One way that prospective job candidates ... [Published Creative Times - Aug 27 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

La Jolla Pharmaceutical Company Announces First Patient Enrolled in Clinical Trial of LJPC-501 in Hepatorenal Syndrome

SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ: LJPC), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that the first patient has been enrolled ... [Published Investor's Business Daily - Aug 25 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Diabetic teen conquers mountain in Peru

Determined not to let his condition come in the way of achieving new heights, a Pune boy with Type-1 diabetes successfully scaled a mountain in Peru recently, as a part of an event organised by a pharmaceutical company and the Diabetes Care Research ... [Published Mid Day - Aug 22 2014]
Entities: Diabetes, Peru, Insulin
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

JDRF Walk Aims to End Type 1 Diabetes

David Ising.David Ising serves as Board President of the JDRF Kentucky and Southern Indiana Chapter, dedicating his spare time to help find a cure for Type 1 Diabetes. The disease affects over 40,000 individuals and their families in Kentucky, including ... [Published Louisville Voice-Tribune - Aug 21 2014]
Entities: Insulin, Diabetes, Pancreas
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Frederick Memorial Hospital Answers Questions Regarding Patients' Status

FREDERICK , Md. - A lot of questions have been raised regarding a patient's status when they visit Frederick Memorial Hospital and where their insurance coverage comes into play.In order to determine whether Medicare will cover the costs or not, it is ... [Published NBC25 - Aug 21 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial

AbstractBackground The mainstay of treatment for acutely decompensated heart failure (ADHF) is intravenous diuretic therapy either as a bolusor via continuous infusion.Objectives We evaluated the clinical effects and safety of three strategies of intravenous ... [Published Emergency Medicine Journal - Aug 14 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

International Fracture Repair Society Meeting

Meeting News CoverageNEW YORK — Results of a prospective randomized trial presented here indicate use of a continuous popliteal sciatic nerve block reduces rebound pain in patients who underwent surgery for ankle fractures better than a single-injection ... [Published Orthopedics Today - Aug 12 2014]
First reported Aug 11 2014 - Updated Aug 11 2014 - 1 reports

ICASA outlines council processes

The Independent Communications Authority of SA (ICASA) has issued a right of reply to an article published by ITWeb last month, " ICASA council set for shake-up ", which it believes to be "inaccurate and highly misleading".The said article was a product ... [Published IT Web - Aug 11 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

Nobody's Poster Child

I was introduced to Terry by her screams of pain filling the hall of the hospital. Her parents had transferred her from an out-of-town hospital when someone there gave them my name as a recommendation. I had been in practice only a few years—I did not ... [Published Cancernetwork.com - Aug 01 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

Children with diabetes ‘lose out’

Children’s health will suffer with the loss of a quality paediatric diabetes service at University Hospital Limerick, a national campaign group has warned.Over the last year, children’s diabetes services at the hospital had improved dramatically with ... [Published Irish Examiner - Jul 31 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Measurement of the efficacy of 2% lipid in reversing bupivacaine- induced asystole in isolated rat hearts

Research articleHongfei Chen , Yun Xia , Binbin Zhu , Xiawei Hu , Shihao Xu , Limei Chen , Thomas J Papadimos , Wantie Wang , Quanguang Wang and Xuzhong XuBMC Anesthesiology 2014, 14 :60doi:10.1186/1471-2253-14-60Published: 30 July 2014Abstract (provisional) ... [Published BMC - Jul 30 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

Flamel Technologies Announces FDA Approval of VAZCULEP

LYON, FRANCE--(Marketwired - Jun 30, 2014) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for VAZCULEPT (phenylephrine hydrochloride). VAZCULEP ... [Published Marketwire - Breaking News Releases - Jun 30 2014]

Quotes

"There's something whether to be expected for short term or not. But there's also the severity of that illness. The intensity of the treatment, so if someone say is on a continuous infusion of medicine, that's much more substantial than if they're on oral medication" added Dr. Trumble
"The early intervention of the present invention may be within 24 hours, within 20 hours, within 16 hours, within 12 hours, within 8 hours, within 4 hours, within 2 hours, or within 1 hour of clinical assessment of the patient."

More Content

All (27) | News (25) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
MS SQL Certification: Is It Worth The Time, Tro... [Published Creative Times - Aug 27 2014]
La Jolla Pharmaceutical Company Announces First... [Published Investor's Business Daily - Aug 25 2014]
Diabetic teen conquers mountain in Peru [Published Mid Day - Aug 22 2014]
JDRF Walk Aims to End Type 1 Diabetes [Published Louisville Voice-Tribune - Aug 21 2014]
Frederick Memorial Hospital Answers Questions R... [Published NBC25 - Aug 21 2014]
Identification and basic management of bleeding... [Published American Board of Family Practice - Aug 20 2014]
New Challenge of Developing Combined Radio-Drug... [Published General Medicine eJournal - Aug 20 2014]
Clinical effects and safety of different strate... [Published Emergency Medicine Journal - Aug 14 2014]
"Methods of Treating Cardiovascular Indications... [Published HispanicBusiness.com - Aug 14 2014]
Agonists of neurotrophin receptors and their us... [Published PharmCast - Aug 14 2014]
An antidote for Factor Xa inhibitors [Published Drug Discovery News - Aug 13 2014]
International Fracture Repair Society Meeting [Published Orthopedics Today - Aug 12 2014]
Flamel Technologies Announces FDA Approval of V... [Published Flamel Technologies S.A. - Aug 11 2014]
ICASA outlines council processes [Published IT Web - Aug 11 2014]
Portola Pharmaceuticals' (PTLA) CEO Bill Lis on... [Published Seeking Alpha - Aug 07 2014]
Nobody's Poster Child [Published Cancernetwork.com - Aug 01 2014]
Children with diabetes ‘lose out’ [Published Irish Examiner - Jul 31 2014]
Measurement of the efficacy of 2% lipid in reve... [Published BMC - Jul 30 2014]
Flamel Technologies' (FLML) CEO Michael Anderso... [Published Seeking Alpha - Jul 29 2014]
MicroRNA-140-5p as a tumor suppressor and sensi... [Published PharmCast - Jul 18 2014]
Flamel Technologies Announces FDA Approval of V... [Published Marketwire - Breaking News Releases - Jun 30 2014]
Portola Pharmaceuticals Begins Enrollment in Ph... [Published GlobeNewswire - May 12 2014]
EHR Story for Mother's Day 2014: Even The Forme... [Published Health Care Renewal - May 09 2014]
Methods and compositions for treatment of human... [Published PharmCast - Apr 28 2014]
Portola Pharmaceuticals starts Phase III trial ... [Published Pharmaceutical Business Review - Mar 20 2014]
Portola reports additional positive results fro... [Published Pharmaceutical Business Review - Dec 10 2013]
Novo Nordisk, Roche Diabetes to make insulin pu... [Published PharmaBiz - Nov 25 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Flamel Technologies Announces FDA Approval of V... [Published Marketwire - Breaking News Releases - Jun 30 2014]
LYON, FRANCE--(Marketwired - Jun 30, 2014) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for VAZCULEPT (phenylephrine hydrochloride). VAZCULEP ...
EHR Story for Mother's Day 2014: Even The Forme... [Published Health Care Renewal - May 09 2014]
[Note to the humorless:  this post is satirical to make a very serious point, a point too often ignored by those who know better.  If you don't like satire, don't read it.]I've been critiqued for posting in too gloomy a manner for some's taste, even those ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.